News

Five New European Bauhaus Lighthouse demonstrators projects selected

Published on | 3 years ago

Programmes Missions New European Bauhaus

The results of the mission call Support the deployment of lighthouse demonstrators for the New European Bauhaus initiative in the context of Horizon Europe missions (HORIZON-MISS-2021-NEB-01) are announced. Five projects have been selected for this call and will each receive a funding of  approximately €5 million to implement their plans in 13 EU Member States and Associated Countries: Belgium, Czechia, Germany, Denmark, Greece, Croatia, Italy, Latvia, Netherlands, Slovenia, Portugal, Norway and Turkey.

The selected projects will bring innovative ideas and solutions in helping to point the way forward for other New European Bauhaus actions and will also contribute to the EU Missions.

To read the full press release click here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1683 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.